Vitrolife AB (CHIX:VITRS) Retained Earnings: kr-6,668 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:VITRS Vitrolife AB CHIX:VITRS
80 GF Score
Price kr86.38
GF Value kr185.92
! 6 Warning Signs
View Full Analysis

What is Vitrolife AB Retained Earnings?

Vitrolife AB CHIX:VITRS 80 Retained Earnings is kr-6,668 Mil as of Jun. 2026. GuruFocus rates CHIX:VITRS with a GF Score™ of 80/100 and a GF Value™ of kr185.92. The stock has 6 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Vitrolife AB's retained earnings for the quarter that ended in Jun. 2026 was kr-6,668 Mil.

Vitrolife AB's quarterly retained earnings increased from Dec. 2025 (kr-6,755 Mil) to Mar. 2026 (kr-6,650 Mil) but then declined from Mar. 2026 (kr-6,650 Mil) to Jun. 2026 (kr-6,668 Mil).

Vitrolife AB's annual retained earnings increased from Dec. 2023 (kr-1,993 Mil) to Dec. 2024 (kr-1,608 Mil) but then declined from Dec. 2024 (kr-1,608 Mil) to Dec. 2025 (kr-6,755 Mil).


Vitrolife AB  (CHIX:VITRs) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Vitrolife AB Retained Earnings Historical Data

* Premium members only.

The historical data trend for Vitrolife AB's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitrolife AB Retained Earnings Chart

Vitrolife AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,730.00 2,000.00 -1,993.00 -1,608.00 -6,755.00

Vitrolife AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,549.00 -1,444.00 -6,755.00 -6,650.00 -6,668.00
CHIX:VITRS
80GF Score
Vitrolife AB CHIX:VITRS
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vitrolife AB Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of kr-6,668 Mil mean?
Vitrolife AB (CHIX:VITRS) has a Retained Earnings of kr-6,668 Mil as of Jun. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Vitrolife AB and its competitors.
Is Vitrolife AB's Retained Earnings too high?
Vitrolife AB's current Retained Earnings is kr-6,668 Mil. Overall, Vitrolife AB has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Vitrolife AB's Retained Earnings compare to ABT and SYK?
Vitrolife AB's Retained Earnings of kr-6,668 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Devices & Instruments company?
A good Retained Earnings depends on the Medical Devices & Instruments industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Vitrolife AB and its competitors. Vitrolife AB's current Retained Earnings is kr-6,668 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrolife AB stock overvalued right now?
Vitrolife AB (CHIX:VITRS) has a current Retained Earnings of kr-6,668 Mil. The stock's GF Value™ is kr185.92, compared to a current price of kr86.38 — trading 53.5% below its estimated fair value. The current Retained Earnings is kr-6,668 Mil. Vitrolife AB's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Vitrolife AB (CHIX:VITRS), the current Retained Earnings is kr-6,668 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vitrolife AB (CHIX:VITRS) Overvalued in 2026?

Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued. The current stock price of kr86.38 is trading 53.5% below its estimated GF Value™ of kr185.92.

Key valuation signals for CHIX:VITRS:

  • Retained Earnings: kr-6,668 Mil
  • GF Value™: kr185.92 vs. price of kr86.38 (53.5% below fair value)
  • GF Score™: 80/100 with 6 warning signs

No single metric tells the full story. See the CHIX:VITRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vitrolife AB Business Description

Address Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
80GF Score

Get the complete analysis for CHIX:VITRS

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr86.38
Price
kr185.92
GF Value